Intellectual property, drug licensing, freedom of information, and public health
Lancet
.
1998 Aug 29;352(9129):726-9.
doi: 10.1016/S0140-6736(98)07600-4.
Authors
I Roberts
1
,
A L Po
,
I Chalmers
Affiliation
1
Department of Epidemiology and Public Health, Institute of Child Health, London, UK.
PMID:
9729005
DOI:
10.1016/S0140-6736(98)07600-4
No abstract available
MeSH terms
Albumins / therapeutic use
Clinical Trials as Topic
Communication
Drug Approval* / legislation & jurisprudence
Drug Industry*
Government Agencies
Humans
Intellectual Property*
Public Health
United Kingdom
Substances
Albumins